Risk factors for cyclosporine A‐associated hypertension in dermatology
International Journal of Dermatology · 2024
DOI: 10.1111/ijd.17309 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Soo Ran Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul Metropolitan Government-Seoul National University (SMG-SNU) Boramae Medical Center, Seoul, South Korea. Hauptthemen laut MEDLINE: Cyclosporine, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Chong Kun Dang Pharmaceutical Corporation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Seoul Metropolitan Government-Seoul National University (SMG-SNU) Boramae Medical Center, Seoul, South Korea.
- Medical Research Collaborating Center, Seoul Metropolitan Government-Seoul National University (SMG-SNU) Boramae Medical Center, Seoul, South Korea.
- Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.
ORCID-Profile: Soo Ran Lee, Soyun Cho
Förderung
- Chong Kun Dang Pharmaceutical Corporation
Zitieren
APA
Lee, S. R., Oh, S., & Cho, S. (2024). Risk factors for cyclosporine A‐associated hypertension in dermatology. International Journal of Dermatology. https://doi.org/10.1111/ijd.17309
Vancouver
Lee SR, Oh S, Cho S. Risk factors for cyclosporine A‐associated hypertension in dermatology. International Journal of Dermatology. 2024. doi:10.1111/ijd.17309
BibTeX
@article{Lee2024,
author = {Lee, Soo Ran and Oh, Sohee and Cho, Soyun},
title = {Risk factors for cyclosporine A‐associated hypertension in dermatology},
journal = {International Journal of Dermatology},
year = {2024},
doi = {10.1111/ijd.17309}
}
EUVIMED